KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Change in Receivables: 2009-2024

Historic Change in Receivables for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $39.4 million.

  • Cme Group's Change in Receivables fell 185.86% to -$25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year decrease of 80.36%. This contributed to the annual value of $39.4 million for FY2024, which is 23.50% down from last year.
  • Per Cme Group's latest filing, its Change in Receivables stood at $39.4 million for FY2024, which was down 23.50% from $51.5 million recorded in FY2023.
  • In the past 5 years, Cme Group's Change in Receivables ranged from a high of $51.5 million in FY2023 and a low of -$28.2 million during FY2020.
  • Over the past 3 years, Cme Group's median Change in Receivables value was $51.1 million (recorded in 2022), while the average stood at $47.3 million.
  • As far as peak fluctuations go, Cme Group's Change in Receivables soared by 262.06% in 2021, and later fell by 23.50% in 2024.
  • Cme Group's Change in Receivables (Yearly) stood at -$28.2 million in 2020, then soared by 262.06% to $45.7 million in 2021, then climbed by 11.82% to $51.1 million in 2022, then climbed by 0.78% to $51.5 million in 2023, then dropped by 23.50% to $39.4 million in 2024.